Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Allison Singier
Observed name:
Allison SINGIER
Institutions:
Conservatoire National des Arts et Métiers,
Inserm,
Agence Nationale de Sécurité du Médicament et des Produits de Santé,
Epi-Phare,
l'Assurance Maladie
Observed institutions:
Conservatoire National des Arts et Métiers,
Inserm,
Agence Nationale de Sécurité du Médicament et des Produits de Santé,
Epi-Phare,
l'Assurance Maladie
ORCID:
0000-0003-3151-6299
Observed ORCID:
0000-0003-3151-6299
OpenAlex ID:
A5127893157
Real-World Use of Dostarlimab Plus Chemotherapy in Advanced or Recurrent Endometrial Cancer: A Nationwide Cohort Study in France
2026
·
Allison Singier
, Stéphane Vignot
, et al.
·
BioDrugs
·
1
PDF
Use, survival, and adverse events of dostarlimab monotherapy in advanced or recurrent endometrial cancer: a nationwide cohort study in France
2026
·
Allison Singier
, Stéphane Vignot
, et al.
·
The Oncologist
PDF
Correction: Real-World Use of Dostarlimab Plus Chemotherapy in Advanced or Recurrent Endometrial Cancer: A Nationwide Cohort Study in France
2026
·
Allison Singier
, Stéphane Vignot
, et al.
·
BioDrugs
PDF
Utilisation en vie réelle de l’association dostarlimab-chimiothérapie dans le cancer de l’endomètre avancé ou récidivant
2026
·
Allison SINGIER
, Stéphane VIGNOT
, et al.
·
Journal of Epidemiology and Population Health
Show more works
View as search
Works count:
4
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type